Skip to main content
. Author manuscript; available in PMC: 2013 Jul 10.
Published in final edited form as: Curr Hematol Malig Rep. 2013 Jun;8(2):132–140. doi: 10.1007/s11899-013-0153-6

Figure 2.

Figure 2

Estimates of the probability of overall survival and disease-free survival for AML CR1 patients with negative versus positive MRD via multi-parametric flow cytometry results pre-allo-HCT.[12]